GNI Group Ltd. — Investor Relations & Filings
Filings indexed
93
across all filing types
Latest filing
2023-03-31
Governance Information
Country
JP
Japan
Listing
T
2160
GNI Group Ltd. is a vertically integrated, multinational biopharmaceutical company engaged in the full spectrum of drug development, from research and clinical trials to manufacturing, sales, and marketing. The company's portfolio includes pharmaceutical drugs, traditional Chinese medicines, and medical devices. Its research and development efforts are primarily focused on creating therapies for diseases such as cancer and inflammation, with a particular emphasis on conditions prevalent in Asian populations. The group utilizes genetic information and analysis technology to advance its drug discovery programs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 内部統制報告書－第22期(2022/01/01－2022/12/31) | 2023-03-31 | Japanese | |
| 有価証券報告書－第22期(2022/01/01－2022/12/31) | 2023-03-31 | Japanese | |
| 確認書 | 2022-11-14 | Japanese | |
| 四半期報告書－第22期第3四半期(令和4年7月1日－令和4年9月30日) | 2022-11-14 | Japanese | |
| 確認書 | 2022-08-15 | Japanese | |
| 四半期報告書－第22期第2四半期(令和4年4月1日－令和4年6月30日) | 2022-08-15 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
2 filings
| |||||
| 7570443 | 内部統制報告書－第22期(2022/01/01－2022/12/31) | 2023-03-31 | Japanese | ||
| 7570445 | 有価証券報告書－第22期(2022/01/01－2022/12/31) | 2023-03-31 | Japanese | ||
|
2022
10 filings
| |||||
| 7583634 | 確認書 | 2022-11-14 | Japanese | ||
| 7583624 | 四半期報告書－第22期第3四半期(令和4年7月1日－令和4年9月30日) | 2022-11-14 | Japanese | ||
| 7590679 | 確認書 | 2022-08-15 | Japanese | ||
| 7590677 | 四半期報告書－第22期第2四半期(令和4年4月1日－令和4年6月30日) | 2022-08-15 | Japanese | ||
| 7608735 | 四半期報告書－第22期第1四半期(令和4年1月1日－令和4年3月31日) | 2022-05-16 | Japanese | ||
| 7610497 | 確認書 | 2022-04-28 | Japanese | ||
| 7610500 | 訂正有価証券報告書－第21期(令和3年1月1日－令和3年12月31日) | 2022-04-28 | Japanese | ||
| 7613495 | 確認書 | 2022-03-28 | Japanese | ||
| 7613494 | 内部統制報告書－第21期(令和3年1月1日－令和3年12月31日) | 2022-03-28 | Japanese | ||
| 7613501 | 有価証券報告書－第21期(令和3年1月1日－令和3年12月31日) | 2022-03-28 | Japanese | ||
|
2021
3 filings
| |||||
| 7622214 | 四半期報告書－第21期第3四半期(令和3年7月1日－令和3年9月30日) | 2021-11-15 | Japanese | ||
| 7627700 | 四半期報告書－第21期第2四半期(令和3年4月1日－令和3年6月30日) | 2021-08-13 | Japanese | ||
| 7671668 | 四半期報告書－第21期第1四半期(令和3年1月1日－令和3年3月31日) | 2021-05-17 | Japanese | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
GNI Group Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13513/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13513 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13513 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13513 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13513}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GNI Group Ltd. (id: 13513)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.